Nanoparticles and Antiviral Vaccines

Nanoparticles and Antiviral Vaccines - MDPI

We reviewed recent advances of nanoparticles in the development of next-generation vaccines against influenza viruses, coronaviruses, HIV, hepatitis viruses, ...

Nanoparticles and Antiviral Vaccines - PubMed

We reviewed recent advances of nanoparticles in the development of next-generation vaccines against influenza viruses, coronaviruses, HIV, hepatitis viruses, ...

Nano-based approaches in the development of antiviral agents and ...

A conventional method to protect against influenza virus is vaccination with a trivalent inactivated influenza vaccine (TIV), including two influenza A viruses ...

Nanovaccines: A game changing approach in the fight against ...

Nanovaccines are made up of nanoscale-based particles that are connected to or specially prepared with components to stimulate the immune system. Nanovaccines ...

Strategies for developing self-assembled nanoparticle vaccines ...

The adjuvanted nanoparticle vaccine triggered more Th1-oriented cellular immunity, while the non-adjuvanted nanoparticle vaccine resulted in a ...

Nanoparticle Vaccines Adopting Virus-like Features for Enhanced ...

This review covers the advances in vaccine nanotechnology with a perspective on the advantages of virus mimicry towards immune potentiation.

How nano can fight the virus | Nature Materials

Both vaccines incorporate strands of mRNA encoding the 'spike' docking protein of the virus, so that this antigen is produced in the body of a ...

Nanoparticle-Based Vaccines Against Respiratory Viruses - Frontiers

This short review provides an overview of the advantages associated with the use of nanoparticles as vaccine delivery platforms to immunize against respiratory ...

Systemic antiviral immunization by virus-mimicking nanoparticles ...

A versatile vaccination strategy that boosts antiviral immune responses by using erythrocytes decorated with virus-mimetic nanoparticles.

Protein-based antigen presentation platforms for nanoparticle ...

One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface.

An overview on nanoparticle-based strategies to fight viral infections ...

Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have ...

Engineering Antiviral Vaccines | ACS Nano - ACS Publications

In this review, we present recent advances in vaccine development by focusing on vaccine discovery, formulation, and delivery devices enabled by alternative ...

Nanoparticles as a novel and promising antiviral platform in ...

Currently, there is no licensed RVFV vaccine available for human use. Therefore, effective therapeutics are urgently needed. Silver ...

Emerging Advances of Nanotechnology in Drug and Vaccine ... - MDPI

Reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel ...

Nanostrategies to Develop Current Antiviral Vaccines

A number of viral infections still do not have a vaccine or efficient treatment and it is imperative to search for vaccines to control these ...

Nanoparticle vaccines against viral infections | Archives of Virology

Nanotechnology has been applied to vaccine development and optimization using several sophisticated nanoparticle (NP) systems to improve antigen ...

(PDF) Nanoparticles and Antiviral Vaccines - ResearchGate

We also discussed the therapeutic potential of nanoparticles in developing safe and effective mucosal vaccines. Nanoparticle techniques could be ...

Nanotechnology for the management of COVID-19 during the ...

Antiviral nanomateri- als are also emerging as pandemic countermeasures. [5]. Nanoparticles have been prominent in mRNA vaccine designs, where lipid ...

Contribution of Nanotechnologies to Vaccine Development and ...

Furthermore, nanotechnology is considered helpful not only to improve the antiviral molecule delivery but also to supply the viral component(s) ...

Nanoparticle‑based antiviral strategies to combat the influenza virus ...

AuNPs are biocompatible and can be functionalized with antigens as carriers for the delivery of vaccines (18). However, AuNPs cannot inhibit ...